It is important to note that some individuals on Ozempic may experience reduced appetite or nausea, which can make dietary changes challenging
The manufacturer is Novo Nordisk
Although clinical trials show encouraging results, challenges such as variability in histological outcomes, limited long-term data, and high costs persist
The mechanism of Intralipid -mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases
These include myocardial infarction, hepatic IRI, septic shock, and cerebral IRI, as evidenced in studies [37, 83, 86, 118]